Drug repositioning for SARS-CoV-2 by Gaussian kernel similarity bilinear matrix factorization.

Wang, Yibai; Xiang, Ju; Liu, Cuicui; Tang, Min; Hou, Rui; Bao, Meihua; Tian, Geng; He, Jianjun; He, Binsheng

Wang, Yibai; Xiang, Ju; Liu, Cuicui; Tang, Min; Hou, Rui; Bao, Meihua; Tian, Geng; He, Jianjun; He, Binsheng.

Afiliação

Wang Y; School of Information Engineering, Changsha Medical University, Changsha, China.
Xiang J; School of Information Engineering, Changsha Medical University, Changsha, China.
Liu C; Academician Workstation, Changsha Medical University, Changsha, China.
Tang M; School of Information Engineering, Changsha Medical University, Changsha, China.
Hou R; School of Life Sciences, Jiangsu University, Zhenjiang, Jiangsu, China.
Bao M; Geneis (Beijing) Co., Ltd., Beijing, China.
Tian G; Qingdao Geneis Institute of Big Data Mining and Precision Medicine, Qingdao, China.
He J; School of Pharmacy, Changsha Medical University, Changsha, China.
He B; Key Laboratory Breeding Base of Hunan Oriented Fundamental and Applied Research of Innovative Pharmaceutics, Changsha Medical University, Changsha, China.

Front Microbiol ; 13: 1062281, 2022.

Article em En | MEDLINE | ID: mdl-36545200

Palavras-chave

SARS-CoV-2; bilinear matrix factorization; drug repositioning; machine learning; molecular docking

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Microbiol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google